Lilly capitalizing on demand for testosterone drugs
The market for testosterone-replacement treatments is growing, but health experts say overuse of the drugs can be dangerous.
Health Care
Articles
Eli Lilly’s Cialis faces faster-acting competition
A Vivus Inc. pill that is supposed to provide erections within 15 minutes, about half the time or less than Eli Lilly and Co.'s Cialis or Pfizer Inc.’s Viagra, has received U.S. regulatory approval.
State’s high court to weigh in on lawsuit over IU Health billing
Indiana's hospital boards and trial lawyers are closely monitoring a lawsuit that accuses the state's largest hospital group of charging uninsured patients more for treatment than insured patients.
Report: Rebates from health care law will top $1B
More than 3 million health insurance policyholders and thousands of employers will share $1.3 billion in rebates this year, thanks to health care reforms, a research group said Thursday. Indianapolis-based WellPoint Inc. is expected to return $94 million.
WellPoint sees $100 billion ‘duals’ market as care shifts
Indianapolis-based WellPoint Inc. sees a $100 billion market in the states it serves to provide managed care for poor, elderly patients in the Medicare and Medicaid programs.
Lilly tops analyst expectations despite shrinking profit, revenue
Lilly’s quarterly sales and profit fell due to lost patent protection on Gemzar and Zyprexa. But sales of antidepressant Cymbalta, blood thinner Effient, animal health products and sales in China grew by 20 percent or more.
IU Health to give $75 million to IU medical researchers
Indiana University Health announced Tuesday that it will give $75 million in additional funding over the next five years to ramp up research at the Indiana University School of Medicine and launch more clinical trials around the state.
HealthNet names new president and CEO
The Indianapolis-based not-for-profit network of health care centers said J. Cornelius Brown, who arrives from Swope Health Services in Kansas City, Mo., will replace the retiring Booker Thomas.
IU doc group becomes Eskenazi Medical
A group of 123 doctors, nurse practitioners and physician assistants have formed the Eskenazi Medical Group in order to focus on maximizing patient care and related bonus payments at Wishard Health Services.
Integra Specialty Hospital in Muncie closing
Seventy-two employees will lose their jobs when the 32-bed long-term-care facility shuts down on June 17. The company that operates the hospital did not provide a reason for the closing.
WellPoint enrolls IBM supercomputer at IU medical school
IBM’s supercomputer Watson is already a “Jeopardy!” champion. Now, three doctors in Indianapolis are trying to teach it how to treat cancer.
Purdue set to start building life sciences park
The $38 million Lyles-Porter Hall will house numerous health programs. Purdue also is planning a $25 million Drug Discovery Building that will bring together pharmaceutical researchers from throughout the school.
Poison pills remain as Lilly shareholder vote falls short
The proposal garnered support from the owners of 62 percent of Eli Lilly’s outstanding shares. To pass, the proposal needed approval from the owners of 80 percent of Lilly’s shares.
Q&A
Sam Gibbs is president of eHealth Government Solutions, part of California-based eHealthInsurance Services Inc. The company, founded in 1997, pioneered the sale of health insurance over the Internet. Gibbs spoke about the options for public and private health insurance exchanges, including the state-based exchanges mandated by the Patient Protection and Affordable Care Act.
Endocyte could get $1B from Merck development deal
Endocyte Inc. stock more than doubled in premarket trading after the company entered into an agreement to develop its ovarian cancer treatment with pharmaceutical giant Merck & Co.
Is health care bubble about to burst?
Citigroup economist writes that U.S. health care sector "reminds us somewhat ominously of the bubble in housing finance" because public spending is fueling private profits.
Indy is poster child (again) for medical arms race
Indianapolis was highlighted in a new national study because its hospitals have been particularly aggressive at expanding their geographic reach—raising concerns among health insurers and even hospitals themselves that new medical facilities and market power can only lead to higher prices.
Lilly CEO says cost-cutting won’t solve sales losses
Eli Lilly and Co., facing generic competition to two of its top drugs, needs to rely on new medicines rather than cost-cutting to overcome the revenue loss, CEO John Lechleiter said Thursday in Boston at the annual meeting of the Pharmaceutical Research and Manufacturers of America.
Loss of St. Francis puts Beech Grove at crossroads
There is a mix of sadness, grief and anger in Beech Grove, as Franciscan Alliance moves the last of its inpatient and emergency operations from its nearly 100-year-old Beech Grove hospital to the new Franciscan St. Francis facility at Stop 11 Road and Emerson Avenue.
Cook Group acquires local biotech company
Bloomington-based medical device maker Cook Group has acquired General BioTechnology LLC, an Indianapolis biotech company with about 20 employees, Cook Group announced Monday.